Virohan secures $7 million to expand their business and also enter the Japanese market.

Virohan raises 7$ million to set-up 200 new campuses pan-India. Virohan is an education based healthcare set-up who aims to train students by providing courses in healthcare sectors.

Education-based healthcare start-up has raised $7 million in a pre-Series B1 round headed by Blume Ventures. It also included $500,000 from Harshvardhan Rajgarhia as part of LetsVenture, ALES Japan, Shantanu Jain (Managing Director, JP Morgan Chase – Singapore), Deepa Bagla Financial Consultants, and others. Bharat Inclusion Seed Fund, Rebright Partners, and Lesing Artha Limited all contributed to the fundraising.

The company intends to use the funds to train more than 7,000 students and expand to over 200 new campuses across India.

“In the next 18 months, Virohan will deepen its relationship with its stakeholders (Students, Universities/Colleges and Medical institutions), train over 10,000 students, and establish an international presence to cater to $100 billion+ global opportunity,” said Kunaal Dudeja, Co-founder and CEO, Virohan.

Virohan is an education-based healthcare start-up that focuses on providing courses to students to build a career in the healthcare industry. They offer courses like Emergency Medical Technician, Medical Laboratory Technician, Operation Theatre Technician, Hospital Administration, Radiology Technician.

In addition to their new expansion plans company intends to develop new features. According to a news statement by Virohan, this money will also aid the business' expansion into Japanese markets with the assistance of its current investors ALES and Rebright Partner.

Tags : #fundingalert #education #healthcare #healthcarecourses #betterfuture #smitakumar #medicircle

About the Author

Mansi Kamble

I like listening to music, love reading and writing is my passion. Healthcare has always been a curious topic for me. I even watched some medical dramas like Chicago Med & Grey's Anatomy. So, here I am exploring my passion in the field of my interest.

Related Stories

Loading Please wait...